4.7 Article

Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques

期刊

ANTIVIRAL RESEARCH
卷 112, 期 -, 页码 103-112

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2014.10.008

关键词

Rhesus macaques; Toll-like receptor 3 (TLR3); Simian immunodeficiency virus (SIV); CC chemokine; Interferon; microRNA

资金

  1. National Natural Science Foundation of China [81271334, 81201261, 81301428]
  2. National Institutes of Health of United States [DA012815, DA027550, DA022177, DA36413]
  3. Foundation of Scientific and Technological Project of Hubei Province [2014CFA076]
  4. Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine) [WDCM005]

向作者/读者索取更多资源

Toll-like receptor 3 (TLR3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate antiviral immunity against viral infections. Here we demonstrate that TLR3 signaling of monocyte-derived macrophages (MDM) from rhesus monkeys by poly I:C inhibited simian immunodeficiency virus (SIV) infection and replication. Investigation of the mechanisms showed that TLR3 activation resulted in the induction of type land type III interferons (IFNs) and IFN-inducible antiviral factors, including APOBEC3G (MG), tetherin and SAMHD1. In addition, poly I:C-treated macaque macrophages expressed increased levels of CC chemokines including CCL3, CCL4 and CCL5, the ligands for HIV or Sly coreceptor CCR5. Furthermore, TLR3 signaling of macaque macrophages induced the expression of cellular microRNAs (miR-29a, -29b, -146a and -9), the newly identified intracellular SIV restriction factors. TLR3 activation-mediated anti-Sly effect could be compromised by the knockdown of IRF3 and IRF7. These findings indicate that TLR3-mediated induction of multiple viral restriction factors contribute to the inhibition of SIV infection in macaque macrophages, which support future preclinical studies using rhesus macaques to determine whether in vivo TLR3 activation is safe and beneficial for treating people infected with HIV. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据